EHA 2022 | Perspectives on patient selection for CAR-T therapy

Name: Perspectives on patient selection for CAR-T therapy
Uploaded: 2022-06-10T00:00:00Z
Duration: 1 min 52 s
Description: Ulrich Jäger, MD, Medical University of Vienna, Vienna, Austria, discusses patient selection for CAR-T therapy, drawing focus on factors that need to be considered when selecting patients and the process of patient selection in the Austrian CAR-T cell network. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

Ulrich Jäger • 10 Jun 2022

EHA 2022

General CAR-T

Ulrich Jäger, MD, Medical University of Vienna, Vienna, Austria, discusses patient selection for CAR-T therapy, drawing focus on factors that need to be considered when selecting patients and the process of patient selection in the Austrian CAR-T cell network. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.